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Background: Newspapers are an important means for the communication of medical
research findings to policy-makers and the public, but may distort their views on the
relative importance of research into, and burden from, different respiratory diseases.
Methods: A systematic search strategy based on respiratory-related keywords was
developed and translated into 15 European languages to identify relevant stories in 26
newspapers from eight countries in 2002-2013. Details of the stories were recorded on
Excel and coded based on the reported respiratory conditions (asthma, chronic
obstructive pulmonary disease (COPD) and other) and research types. Each cited
research study was identified on the Web of Science and downloaded for analysis.
Findings: There were far more stories about asthma than on COPD, although the
amount of research was only modestly greater, and the disease burden far less. Epide-
miology, lifestyle and genetics research received the most media attention but not in
all newspapers, while means of diagnosis and quality of life were under-reported in
all newspapers. Journalists tended to over-cite research from their country by a factor
averaging four times more than other researchers. About 10% of stories included a
quote from a commentator, especially those in the two UK newspapers, with most of
the quotes from UK charities.
Conclusions: The balance between disease areas reported in European newspaper
stories is very misleading. European policy-makers and public may perceive asthma
as more burdensome than it is and COPD much less. The study also showed that UK
charities, but not those in other European countries, gained significant publicity from
their contributions to these stories.
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1 | BACKGROUND
Respiratory conditions are a neglected area of research1–4
with about 4.3% of biomedical funding allocation within the
European Union’s (EU) seventh Framework Programme for
Research and Technological Development (FP7).2 They are
underfunded across Europe in general3 and account only for
2.5%-4.5% of total medical research spending by UK
funding bodies.4 Research on these diseases represented only
0.77% of all biomedical research in Europe in 2002–2013
and 0.55% in the world3.
The burden of non-communicable respiratory diseases
across Europe (EUR31; the 28 European Union Member States,
plus Iceland, Norway and Switzerland) in 2012, averaged 5.1%
of all Disability Adjusted Life Years (DALYs) as estimated by
the World Health Organization.5 The burden varied between
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2.1% in Estonia and 7.7% in the UK.5 Chronic obstructive pul-
monary disease (COPD) caused almost two-thirds of the burden
(2.9% on average) compared with just 1.0% for asthma; how-
ever, the latter received more attention from researchers.2
Across Europe, an estimated 30 million children and adults
under the age of 45 years have asthma and its prevalence, for
both groups, has increased in most European countries.6 In the
UK, there are 8 million people diagnosed with asthma of
which an estimated 5.4 million currently receive treatment.7
The UK and Ireland have among the highest European asthma
rates.6 Pharmacological treatments for asthma, which include
bronchodilators and steroids (inhalers or spacers), provide
good management of asthmatic attacks and the underlying
inflammation and control of their symptoms.8 Deaths due to
asthma, therefore account for only 7% of respiratory deaths at
the global level, and 10% in Europe9 (see Table 1) and the bur-
den from the condition has gone down in consequence.
The prevalence of COPD also varies widely between
European countries due to heterogeneity of diagnostic crite-
ria and methods.10–12 It is estimated that 1.2 million people
live with diagnosed COPD in the UK13 and it is twice as
prevalent in males as in females.14 Because of the lack of
effective treatments to control the progress of the disease,12
COPD accounts for 75% of respiratory disease deaths glob-
ally and 62% in Europe9 (Table 1). COPD is exacerbated by
smoking, and by air pollution, and the WHO estimates of
mortality (persons, all ages, thousands) from all respiratory
diseases are provided in Table 1.9
Previous research evaluated the impact of research papers
in five NCDs from 2002 to 2013 on national health advisory
committees1 and found that less than 2% of research output
was on respiratory medicine, with the exception of the
Netherlands. A second measure of impact, namely the effect
on European clinical guidelines of chronic respiratory condi-
tions’ research in Europe was reported recently3 demonstrat-
ing that the UK and Denmark particularly were influencing
the evidence base on clinical guideline recommendations for
both asthma and chronic obstructive pulmonary disease
(COPD). In this paper, a third measure of impact is
described, namely the extent to which respiratory disease
research is reported in European newspapers.
Media reporting of medical and scientific findings is a
widely recognised means of communication and provision of
information to the public15,16 and health professionals16,17 that
shapes public opinion and influences the policy agenda.18,19
There have been many studies on newspaper and other mass
media reports of medical research and the evaluation of bias
against negative findings, public influence, persuasion or
framing of public-health policy-formation.15–19 However, they
are often limited to a single country.16,18,19 This study differs
because it is a pan-European effort to determine the disease
areas and research types in the field of respiratory conditions.
In this research paper, we have explored the research
hypothesis that the amount of respiratory research reported
in the newspapers of the reflected sub-diseases would
respond to the relative disease burden of each country and/or
its research output. We have investigated which countries’
research has been most frequently cited in the newspaper sto-
ries, and the extent to which journalists have tended to over-
cite research from their own country. We have also looked at
the research domains, or types, such as epidemiology, genet-
ics and pharmaceutical treatments, that the journalists have
selected for their stories.
2 | METHODS
2.1 | Selection of newspapers
Newspapers were originally selected to represent both right
and left wing perspectives in each country. However, due to
time limitations, we restricted our analyses to those with the
greatest circulation. We assembled a multi-national team of
bilingual researchers to help us collect the data. The mem-
bers of the team were trained at KCL by EP to ensure con-
sistent use of methodology and coding of the disease areas
and research domains (see Acknowledgements). Table 2 lists
the newspapers and countries from which the respiratory dis-
ease research stories were taken.
2.2 | Processing of newspaper stories
A systematic search strategy was developed to identify relevant
stories reporting research in respiratory diseases in the selected
TABLE 1 The number of deaths at the global and European level and the contribution of the various respiratory diseases according to the
WHO9
World (000’s) % RESPI, world EUR31 (000’s) % RESPI, EUR31
Respiratory diseases 4,036 374
COPD 3,025 74.9 234 62.5
Asthma 287 7.2 36 9.7
Other respiratory 724 17.9 104 27.8
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European newspapers, either with FactivaVC Dow Jones, or the
newspapers’ own archives. The strategy was as follows:
(Asthma or COPD or chronic obstructive pulmonary
disease or allergic rhinitis or cystic fibrosis or emphy-
sema) and (research* or study or scientists or expert*)
The search statement was translated from English into 15
different languages, of which nine were used for the main EU8
results of this paper (see Table 2). The researchers recorded
salient data from the relevant stories on an Excel database and
included the date, newspaper, headline and synopsis in both
the original language and in English, the journalist’s name and
position, details of the cited research (if available) for example
the scientists’ names and their institution, and the journal in
which the paper was published. The names and affiliations of
any commentators were also recorded.
2.3 | Identification and analysis of selected
research articles
We identified the details of the cited papers from the Web of
Science VC Clarivate Analytics (WoS) and then downloaded
full bibliographic details as individual text files. We converted
these to an Excel spreadsheet by means of a special VBA pro-
gram developed for this purpose by Dr Philip Roe of Evalua-
metrics Ltd. We copied the details of the individual papers
across to the main spreadsheet of stories and analysed the
papers using further VBA programs. We calculated the frac-
tional counts of countries among the addresses on each paper
and classified each paper’s research level on a scale from
1.05 clinical to 4.05 basic, based on words in their titles and
the journals in which they were published.20 The researchers
using their judgement also coded the research domain (eg, epi-
demiology, genetics, nutrition) and respiratory disease
(asthma, COPD, cystic fibrosis and others) based on the study
title, headline and the synopsis of the reported story. Finally,
we listed the names and organisations of any commentators
who were quoted as this was considered to be intentional to
put the significance of the results into context.
2.4 | Statistical analyses
Our analysis covered the types of respiratory conditions as
reported in the newspapers for each country—namely asthma,
COPD, cystic fibrosis and other—and were compared to the
amount of research and the disease burden. For this purpose,
simple dependent t tests were performed. We also analysed
the research levels of the cited papers, self-citations and cita-
tions from other countries, as well as the details of the coun-
tries and sectors of the organisations invited to comment. For
the cited papers, based on the addresses, the research presence
of different countries showed if they were relatively over- or
under-cited in the media. For the analysis of individual coun-
tries’ reporting, we restricted the analysis to those eight coun-
tries whose newspapers included at least 20 stories, to reach
statistically significant conclusions.
3 | RESULTS
3.1 | Respiratory diseases
Overall, from 2002 to 2013, there were 522 respiratory dis-
ease research stories in 26 newspapers from 19 European





newspapers Newspaper Language Stories AST COP OTH
UK 2 Daily Mail; the Guardian English 180 114 10 56
BE 2 De Standaard; Le Soir Flemish and French 61 45 10 6
DK 1 Morgenavisen Jyllands Posten Danish 53 41 9 3
NL 2 De Telegraaf; Het Algemeen Dagblad Dutch 36 34 2 0
IT 1 La Repubblica Italian 27 17 3 7
GR 1 To Bήla (To Vema) Greek 24 15 2 7
RO 1 Adevarul Romanian 24 19 2 3
ES 3 El País; El Mundo; ABC Spanish 22 10 2 10
Total 13 427 295 40 92
BE, Belgium; DK, Denmark; ES, Spain; GR, Greece; IT, Italy; NL, the Netherlands; RO, Romania; UK, United Kingdom.
AST, asthma; COP, chronic obstructive pulmonary disease; CYF, cystic fibrosis; OTH, other respiratory conditions.
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countries. These represented 5.8% of all the newspaper sto-
ries on the five NCDs; this percentage compares with respi-
ratory medicine’s burden of 7.2% to that of the five NCDs,
and its 2.7% share of the EUR31 research output. Figure 1
shows that asthma received 69% of the news coverage, while
COPD received barely 10% and other respiratory diseases
23%. Asthma was the subject of 45% of the European
research outputs, and accounted for 24% of the respiratory
disease burden. But for COPD the situation was reversed,
with 28% of the research and 58% of the burden. There were
differences between the eight selected countries in the
emphasis that they gave to the different diseases, see Table
2. The Netherlands gave most prominence to asthma stories
(94%) and Spain the least (45%); for COPD Denmark (17%)
and Belgium (16%) had the most coverage, and the UK the
least (6%). Compared with these differences, the variations
in the amount of research and disease burden for the different
countries were quite small. In effect, the overall disconnect
between disease reportage and burden was reproduced in all
eight countries. The most cited research study (7 times) in
the 13 newspapers was on the “Association of duration of
television viewing in early childhood with the subsequent
development of asthma”21 published in 2009. This was a UK
paper which was reported seven times by newspapers in Bel-
gium, Denmark, the Netherlands, Romania and the United
Kingdom. Overall, there was one other paper cited five
times, eight papers with four newspaper cites, 14 papers with
three citations, 55 papers with two cites and the remaining
326 papers cited only once, suggesting that these research
papers had a wide influence across the European media.
3.2 | Research domain
The most frequent of the 10 research domains of the stories
were epidemiology (146 stories, 28%) and lifestyle choices
(27%) that could lead to respiratory disease. They were fol-
lowed by genetics (19%), drugs (17%), the effects of diet
or nutrition (11%), toxicology (10%), pathology (7%) and
other treatments (5%). For the eight countries,
pharmacological treatment research received widespread
attention (14% on average) in 11 newspapers (but not
Romania), as shown in Figure 2 (orange sections). Italy
showed a preference for diagnosis research (25%, blue sec-
tion) in comparison with the other European countries,
while in Spain epidemiology received disproportionate
attention. Stories about research on lifestyle (dark blue sec-
tions) were most prominent in the British (45%) and Dan-
ish (40%) newspapers. Quality of life (violet sections)
received no, or very little, attention in the media, with less
than 8% in only three countries. Meanwhile, toxicology
(yellow sections) as a trigger of a respiratory disease, and
pathology (pink sections), which is needed to understand
disease progression, were also neglected subjects.
3.3 | Countries’ research presence and
self-citation
As shown in Figure 3, most European countries’ research
is over-cited in the newspapers compared to their presence
in the world literature, particularly that of the Nordic coun-
tries. Research from non-European countries such as
Korea, China and Asia, as well as non-Anglophone coun-
tries, is relatively neglected, as shown in Table 3, even
though most of it is published in English. In Table 4, these
ratios are presented for papers cited by the newspapers of
the eight individual countries (EU8) (but none from Roma-
nia). The research reported in the media in the eight Euro-
pean countries is on average four times more cited, often
from the journalist’s own country, than would be expected
based on the country’s output in world respiratory research
FIGURE 1 The percentages of newspaper stories, research output in
respiratory diseases and DALYs in the various respiratory conditions in
eight European countries ranked by the percentage of stories on asthma
(AST), followed byCOPD (COP) and other respiratory diseases (OTH)
FIGURE 2 The percentage country contribution to the cited Euro-
pean newspaper research articles (on a log10 scale) compared to the world
literature on respiratory research, Solid line average trendline, dotted lines:
23 up or 0.53 down average trendline. UK, United Kingdom (P< .01);
NL, the Netherlands (P< .01); ES, Spain (n.s.); DK, Denmark (P< .01);
SE, Sweden; DE, Germany (n.s.); IT, Italy (P< .05); FR, France
(P< .01); BE, Belgium (n.s.); FI, Finland (P< .05); GR, Greece (n.s.);
CH, Switzerland (n.s.); DIAG, Diagnosis; DRUG, Pharmacological treat-
ments; EPID, Epidemiology; GENE, Genetics research; LIFE, Lifestyle
factors; NUTR, Diet and nutrition; OTHT, Other types of treatment;
PATH, Pathology; QUAL, Quality of life; TOXI, Toxicology and
pollution.
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(13.3% of the cited articles compared with 4.7% of respira-
tory research papers).
The countries contributing to the cited papers are shown
in Figure 3 as integer counts and plotted against the coun-
tries’ percentage presence in respiratory disease research in
the years 2002–2013, both on log scales. The USA featured
most prominently among the cited papers. In Table 4, the
over-citation ratios (OCR) are presented for papers cited by
the newspapers of the EU8 countries. They tend to cite
research by their fellow-countrymen much more than
expected. For example, Denmark is over-reporting research
in the media, in comparison to what it is producing (research
output), by a factor of 27. In contrast, the Romanian newspa-
per did not cite any Romanian research at all. The OCR for
the newspaper citations was also higher than expected from
the pattern of citations in the WoS, but the difference was
only statistically significant for the UK, Denmark, the Neth-
erlands and Italy.
3.4 | Research level
The research level (RL) of papers is much more clinical than
that of the journals. With one exception, the newspapers are
citing papers of the same mean RL as the generality of
research. The RL of the papers averaged 1.35 (compared
with 1.46); that of the journals in which they were published
averaged 1.82 (compared with 1.76). Therefore, the journal-
ists were selecting both clinical papers and ones in more
basic journals: the papers cited by stories about genetics
were in journals with RL averaging 2.29. Papers about
asthma were in slightly more basic journals (RL j5 1.77,
SEM5 0.039) compared with the much smaller number of
COPD papers (RL j5 1.65, SEM5 0.086).
3.5 | Commentators
There were 83 stories from seven newspapers in five of the
countries that had at least one commentator: Belgium, Den-
mark, Greece, the Netherlands and the UK, while stories
from Italy, Romania and Spain cited no commentators. These
newspaper stories included comments from various research-
ers or senior members of staff in one or more organisations
including charities, universities, hospitals, government
bodies and pharmaceutical companies. The combined list of
the number of results and commenting organisations is given
in Table 5. UK charities are at the top of the list and were
quoted in 26 stories, while none of the other organisation
types/countries contributed more than nine. The proportion
of stories with commentators from the eight European coun-
tries are as follows: from the UK 36%, Denmark 30%, the
Netherlands 11%, Greece 8% and Belgium 5%.
4 | DISCUSSION
This paper examined the reporting of research in respiratory
diseases in 13 newspapers from eight European countries for
the period 2002–2013, and the degree to which they truly
reflect the research efforts in an under-reported research field
like chronic non-communicable respiratory conditions. The
most significant finding was that there is disproportional
reportage of asthma and COPD and within each respiratory
FIGURE 3 The percentages of respiratory research types for the
newspaper stories on respiratory diseases research in eight European
countries for 2002–2013 (scale is more than 100%)
TABLE 3 The non-European countries’ presence in the research
papers cited in the eight European countries’ newspapers (cites), the
percentage presence in world respiratory research from the Web of Sci-
ence (WoS) and the ratio between them; the expected cited respiratory
diseases’ research in the eight European countries’ newspapers in these
non-European countries and the statistical significance
ISO Cites Cites, % WoS, % Ratio Expected P value
US 182 35.14 34.48 1.02 178.6 n.s.
AU 39 7.53 5.27 1.43 27.3 .02
CA 36 6.95 7.42 0.94 38.4 n.s.
NZ 27 5.21 1.13 4.60 5.9 .00
TR 3 0.58 2.01 0.29 10.4 .02
CN 8 1.54 3.26 0.47 16.9 .03
JP 3 0.58 3.99 0.15 20.7 .00
BR 3 0.58 2.44 0.24 12.6 .01
TW 2 0.39 1.11 0.35 5.8 n.s.
KR 1 0.19 2.23 0.09 11.6 .00
Ratios >2 tinted green, >1.41 tinted pale green, <0.5 tinted pink;
n.s., non-significant.
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condition an uneven research attribution in comparison to
the disease burden.
4.1 | Respiratory diseases
We found that asthma research is much more frequently
reported than COPD research in all eight European countries’
newspapers. This finding is robust and demonstrates a sub-
stantial press bias that is likely to make it harder to win public
and policy support for increased funding for COPD research.
Asthma research is more widely reported in newspapers than
COPD, although the latter causes a much higher disease bur-
den. This may be that COPD is a less well understood disease
area for scientists and consequently for the public, which can
explain the lower attention given in the media. This is con-
sistent with previous research indicating that COPD is hugely
underdiagnosed,22 and perhaps this lack of standardised diag-
nostic measures led to a lack of newspaper coverage. This
pattern may be because COPD primarily affects old men, par-
ticularly smokers,23 and they are perhaps less attractive as
subjects for the media. In contrast, of the stories on asthma,
49% involved research on children (including the most cited
study21). This finding may indicate a form of selection bias
and parallels a recent paper that reported that overdiagnosis
of childhood asthma is common in UK primary care.24 The
implication of this finding is the potential impact of public
influence on future research priorities.
4.2 | Research domain
The research type that received the most attention in the
media was pharmaceutical therapies. This re-enforces public
perception that medicines are the key to health improvement,
rather than efforts to reduce smoking, and improve indoor
and outdoor air quality. Diagnosis research in respiratory dis-
eases accounted for fewer than 10% of newspaper stories
TABLE 4 The percentages of the European countries’ presence in the research papers cited in the eight European newspapers, the percentage
presence in the world respiratory research from the Web of Science (WoS), the over-citation ratio (OCR), the expected cited respiratory diseases’
research in the eight European countries’ newspapers in these European countries and the statistical significance in each case
Country ISO Cites Own CU Expected OCR, NSs Sign. OCR, WoS Exp, WoS Sign.
UK 180 69.4 21.00 3.30 0.001 1.76 36.99 0.001
BE 61 6 1.12 5.36 0.001 4.38 4.90 n.s.
DK 53 21.3 0.77 27.75 0.001 3.79 2.91 0.001
NL 36 17.9 1.55 11.56 0.001 2.57 3.99 0.001
IT 27 9.3 1.48 6.27 0.001 2.87 4.26 0.001
GR 24 3.05 0.27 11.16 0.001 4.48 1.22 n.s.
ES 22 4.57 0.88 5.17 0.001 3.83 3.38 n.s.
n.s., non-significant.
TABLE 5 The list of organisation types, assigned codes and number of reported stories present
Type of organisation Examples of commentators N
UK charities the British Lung Foundation, National Asthma Campaign,
National Eczema Society
33
UK non-profits Action on Smoking and Health, British Thoracic Society 11
Danish universities Danish Pediatric Asthma Center at the University of Copenhagen 6
Danish charities Asthma and Allergy Association 4
UK universities Loughborough Sleep Research Centre 4
UK pharma coys GSK 3
Belgian universities Free University Brussels, Liege university 3
Danish pharma coys ALK-Abello East Jutland Innovation 3
Danish hospitals Hvidovre Hospital 2
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(except in Italy). There is either some form of reporting bias
from the media or an underlying preference from Italian, Brit-
ish and Danish scientists to conduct research on respiratory
conditions in these areas. For all chronic respiratory diseases
research in the EU8, quality of life and toxicology reporting
is almost non-existent, in comparison to the great impact that
these have on influencing individuals with asthma, COPD,
emphysema, cystic fibrosis, other respiratory diseases or over-
lap with these conditions or other co-morbidities.
4.3 | Countries research presence and self-
citation
Besides the USA, the UK was also well cited, but because
over one third of the newspaper stories were from the UK,
this high percentage presence may be an artefact. Most of
the European countries were over-cited relative to their pres-
ence in the WoS, but papers from countries in East Asia
were almost neglected. The OCR for all these countries was
much higher than that expected from their percentage pres-
ence in the WoS, especially for the smaller countries.25 Fur-
thermore, the OCR appears stronger for newspaper stories
than for academic articles.
4.4 | Research level
The research level of asthma studies reported in the news-
papers is more basic than that of COPD. This contrasts
with those cited on clinical practice guidelines,3 as the
papers cited in the newspaper stories were comparable in
their research levels to those of European respiratory dis-
ease researchers. This means that research is focused on an
understanding of this heterogeneous disease by examina-
tion of the pathology of the condition or the study of
genetic mutations causing its genesis.26 In comparison,
research on COPD is more clinical, both that published in
the literature and that reported in the newspaper stories.
This is most likely due to concentrated efforts to provide
education on COPD detection, management and smoking
cessation support services in the clinical context.12,27
Essentially, an understanding of risk factors such as indus-
trial pollution hazards and smoking is more relevant to this
disease. The lack of basic research on COPD may be
explained by the difference in the cellular mechanism of
COPD pathology, inflammatory reaction and response to
treatment that is characteristically different from asthma,
leading to the current lack of effective treatments.28
4.5 | Commentators
The main finding was that only the two UK newspapers had
many commentators, mostly charities or non-profit
organisations which thereby gained exposure. This was seen
earlier in a study on the BBC reportage of cancer research.29
The other newspapers cited academics, while newspapers
from three countries invited no comments from any external
organisation. Commentators can provide newspaper readers
with perspective on the research. They also offer free public-
ity to universities, charities, hospitals and research centres
and may influence research priorities and any subsequent
funding.
5 | CONCLUSIONS
Media reporting appears to be heavily biased towards
asthma, with 70% of stories covering this disease while
COPD is under-reported, under-researched and has a dispro-
portionately high disease burden. The media stories on
asthma were more basic, particularly focusing on children in
comparison to COPD reporting which tended to be more
clinical. Diagnosis and quality of life, although greatly influ-
encing the progression of respiratory diseases and their man-
agement, were under-reported in all newspapers. On average,
about one in nine stories received comments from external
organisations, but for the UK newspapers it was one in three.
Commentators from charities and other private-non-profit
organisations thereby gained publicity for their work in the
neglected research area of chronic non-communicable respi-
ratory conditions.
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